Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
- PMID: 34101091
- PMCID: PMC8186356
- DOI: 10.1007/s10875-021-01068-6
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
Conflict of interest statement
The authors declare no competing interests.
References
- 
    - NIH. Clinical spectrum of SARS-CoV-2 infection December 17, 2020 [Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.
 
- 
    - Johns Hopkins University & Medicine CRC. https://coronavirus.jhu.edu/map.html 2021 [
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
 
        